Francesco De Rubertis
Chairman
Centessa Pharmaceuticals plc (CNTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Centessa Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get CNTA alertsAbout Francesco De Rubertis
Francesco De Rubertis is recorded as Chairman at Centessa Pharmaceuticals plc (CNTA). The newest filing on record that lists Francesco De Rubertis as Chairman at Centessa Pharmaceuticals plc (CNTA) is dated May 9, 2024. Centessa Pharmaceuticals plc reported in an 8-K filed June 24, 2026 that Francesco De Rubertis was terminated as Director, effective June 24, 2026. Centessa Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Centessa Pharmaceuticals plc includes Mario Alberto Accardi (CEO and Board Member), John Crowley (CFO), Thomas Templeman (CTO) and 7 others.
“each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa and each committee thereof on which such director served.”
Affiliation history
-
Current
Start not stated–present
Last confirmed May 9, 2024
-
Start not stated–2026-06-24
Company network
Leadership on record at Centessa Pharmaceuticals plc
- Mario Alberto Accardi CEO, Board Member
- John Crowley CFO
- Thomas Templeman CTO
- Iqbal Hussain General Counsel
- Gregory Weinhoff Chief Accounting Officer
- Gregory Weinhoff, M.D., M.B.A. Chief Accounting Officer
- Raphael Deferiere Chief Accounting Officer
- Raphael Deferiere, CPA Chief Accounting Officer
- Christopher Stokes Board Member
- Kristina Mignon Wright Board Member